Progesterone resistance in women who have had breast cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 3, 1998, Pages 345-351

  Simpson, H W ^a   McArdle, C S ^a   Griffiths, K ^b   Turkes, A ^b   Beastall, G H ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE;

ADULT; ARTICLE; BASAL BODY TEMPERATURE; BREAST CANCER; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HORMONE RESISTANCE; HUMAN; LUTEAL PHASE; MASTECTOMY; PRIORITY JOURNAL;

ADULT; BODY TEMPERATURE; BREAST NEOPLASMS; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; POSTOPERATIVE PERIOD; PROGESTERONE; REGRESSION ANALYSIS; SALIVA;

EID: 0031940145     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10098.x     Document Type: Article

References (35)

1. Arai K, Chrousos GP. Glucocorticoid resistance. Clin Endocrinol Metab 1994; 8: 317–332.
2. Komesaroff PA, Funder JW, Fuller PJ. Mineralocorticoid resistance. Clin Endocrinol Metab 1994; 8: 333–356.
3. Hewison M, O'Riordan JLH. Vitamin D resistance. Clin Endocrinol Metab 1994; 8: 305–316.
4. Patterson MN, McPhaul MJ, Hughes LA. Androgen insensitivity syndrome. Clin Endocrinol Metab 1994; 8: 379–404.
5. Auchus RJ, Fuqua SAW. The oestrogen receptor. Clin Endocrinol Metab 1994; 8: 433–450.
6. Williams GR, Franklyn JA. Physiology of the steroid-thyroid hormone nuclear receptor superfamily. Clin Endocrinol Metab 1994; 8: 241–266.
7. Grattarola R. The premenstrual endometrial pattern of women with breast cancer. Cancer 1964; 17: 1119–1122.
8. Mant D, Vessey MP. Epidemiology and primary prevention of breast cancer. In: Bland KI, Copeland EM, editors. The Breast. Philadelphia : WB Saunders, 1991: 235–261.
9. den Tonkelaar I, Blankenstein MA, De Waard F, Collette HJA, Stroo AC. Is decreased luteal function associated with breast cancer [abstract]? In: Proceedings of 4th EORTC Breast Cancer Working Conference 1987; London. European Organisation of Research and Treatment of Cancer: abstract no. BL4.
10. Fischer RH. Progesterone metabolism. Obstet Gynecol 1954; 3: 6, 615–620.
11. Simpson HW, Griffiths K, Pauson AW, Hume P, Turkes A. The luteal heat cycle of the breast in health. Breast Cancer Res Treat 1993; 27: 239–249.
12. IARC Scientific Publication No 120. Parkin, DM, Muir, C, editors. Cancer Incidence in 5 Continents, Vol VI. Lyon, France : International Agency for Research on Cancer, 1992: 828.
13. Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 1985; 6: 5–36.
14. Simpson HW, McArdle CS, Pauson AW, Hume P, Turkes A, Griffiths K. A non-invasive test for the precancerous breast. Eur J Cancer 1995; 31A: 1768–1772.
15. Zuspan KJ, Zuspan FP. Thermogenic alterations in the woman: II. Basal body, afternoon and bedtime temperatures. Am J Obstet Gynecol 1974; 120: 441–445.
16. Read, GF, Bradley JA, Wilson DW, George WD, Griffiths K. Evaluation of luteal phase salivary progesterone levels in women with benign breast disease. Eur J Cancer Clin Oncol 1985; 21: 9–17.
17. Halberg F, Johnson EA, Nelson W, Runge W, Sothern R. Autorhythmomemetry procedures for physiological measurements and their analysis. The Physiology Teacher 1972; 1: 1–11. [Published by American Physiology Society.].
18. Presser HB. Temporal data relating to the human menstrual cycle. In: Ferin M, Halberg F, Richart RM, van den Wiele R, editors. Biorhythms and Human Reproduction. New York : John Wiley, 1974: 158.
19. Matsumoto S, Nogami Y, Ohkuri S. Menstruation in normal women. Gunma J Med Sci 1962; 11: 294–299. [Cited by Presser18.].
20. Armitage P, Berry G. Statistical Methods in Medical Research, Chapter 9.4. Oxford : Blackwell Science, 1987: 273–282.
21. Cannon JG, Dinarello CA. Increased plasma interleukin-1 activity in women after ovulation. Science 1985; 227: 1247–1249.
22. Gold JJ, Borushek S, Smith L, Scominegna A. Synthetic progestins: a review. Int J Fertil 1965; 10: 99–114.
23. Israel SL, Schneller O. The thermogenic property of progesterone. Fertil Steril 1950; 1: 53–65.
24. Johansson ECB, Larsson-Cohn U, Gemzell C. Nonphasic basal body temperature in ovulatory menstrual cycles. Am J Obstet Gynecol 1972; 113: 933–937.
25. Bauman JE. Basal body temperature: unreliable method of ovulation detection. Fertil Steril 1981; 36: 729–733.
26. Moghissi KS. Accuracy of basal body temperature for ovulation detection. Fertil Steril 1976; 27: 1415–1421.
27. Cowan LD, Gordis L, Tonascia JA, Seegar-Jones G. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981; 114: 209–217.
28. Pickles VR. Blood flow estimations as indices of mammary activity. J Obstet Gynaecol Br Emp 1953; 60: 3, 302–312.
29. Mephain TB. Physiology of Lactation. Milton Keynes : Open University Press, 1987.
30. Byers T, Graham S, Rzepka T, Marshall J. Lactation and breast cancer. Evidence for a negative association in premenopausal women. Am J Epidemiol 1985; 121: 664–674.
31. Manning DL, Nicholson RI, Eaton CL. Role of oestrogens and growth factors in the aetiology of breast cancer. In Edwards CRW, Lincoln DW, editors. Recent Advances in Endocrinology and Metabolism. Edinburgh : Churchill Livingstone, 1992: 133–166.
32. Pichon MF, Pallud C, Brunet M, Milgram E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 1980; 40: 133–166.
33. Murphy LC, Dotzlaw H, Wong MSJ, Miller T, Murphy LJ. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Cancer Res 1991; 51: 2051–2057.
34. Sheppard MC, Stewart PM, editors. Hormones, enzymes and receptors. Clin Endocrinol Metab 1994; 8: 305–404.
35. Rosen JM, Matusik RJ, Richards DA, Gupta P, Rodgers JR. Multihormone regulation of casein gene expression at the transcriptional and posttranscriptional levels in the mammary gland. Res Prog Horm Res 1980; 36: 157–193.